Literature DB >> 20075336

Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.

Peiyong Wang1, Jian Liu, Yuquan Li, Sijie Wu, Jinwen Luo, Huan Yang, Ramasamy Subbiah, John Chatham, Olga Zhelyabovska, Qinglin Yang.   

Abstract

RATIONALE: Peroxisome proliferator-activated receptors (PPARs) (alpha, gamma, and delta/beta) are nuclear hormone receptors and ligand-activated transcription factors that serve as key determinants of myocardial fatty acid metabolism. Long-term cardiomyocyte-restricted PPARdelta deficiency in mice leads to depressed myocardial fatty acid oxidation, bioenergetics, and premature death with lipotoxic cardiomyopathy.
OBJECTIVE: To explore the essential role of PPARdelta in the adult heart. METHODS AND
RESULTS: We investigated the consequences of inducible short-term PPARdelta knockout in the adult mouse heart. In addition to a substantial transcriptional downregulation of lipid metabolic proteins, short-term PPARdelta knockout in the adult mouse heart attenuated cardiac expression of both Cu/Zn superoxide dismutase and manganese superoxide dismutase, leading to increased oxidative damage to the heart. Moreover, expression of key mitochondrial biogenesis determinants such as PPARgamma coactivator-1 were substantially decreased in the short-term PPARdelta deficient heart, concomitant with a decreased mitochondrial DNA copy number. Rates of palmitate and glucose oxidation were markedly depressed in cardiomyocytes of PPARdelta knockout hearts. Consequently, PPARdelta deficiency in the adult heart led to depressed cardiac performance and cardiac hypertrophy.
CONCLUSIONS: PPARdelta is an essential regulator of cardiac mitochondrial protection and biogenesis and PPARdelta activation can be a potential therapeutic target for cardiac disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075336      PMCID: PMC2993321          DOI: 10.1161/CIRCRESAHA.109.206185

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  42 in total

1.  Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

Authors:  Yaacov Barak; Debbie Liao; Weimin He; Estelita S Ong; Michael C Nelson; Jerrold M Olefsky; Richard Boland; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

2.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

3.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.

Authors:  Yong-Xu Wang; Chih-Hao Lee; Sambath Tiep; Ruth T Yu; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

4.  Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.

Authors:  Geoffrey D Girnun; Frederick E Domann; Steven A Moore; Mike E C Robbins
Journal:  Mol Endocrinol       Date:  2002-12

5.  Assignment of the gene for cytoplasmic superoxide dismutase (Sod-1) to a region of chromosome 16 and of Hprt to a region of the X chromosome in the mouse.

Authors:  U Francke; R T Taggart
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

6.  Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle.

Authors:  Vamsi K Mootha; Christoph Handschin; Dan Arlow; Xiaohui Xie; Julie St Pierre; Smita Sihag; Wenli Yang; David Altshuler; Pere Puigserver; Nick Patterson; Patricia J Willy; Ira G Schulman; Richard A Heyman; Eric S Lander; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

7.  Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.

Authors:  Janice M Huss; Inés Pineda Torra; Bart Staels; Vincent Giguère; Daniel P Kelly
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.

Authors:  Uwe Dressel; Tamara L Allen; Jyotsna B Pippal; Paul R Rohde; Patrick Lau; George E O Muscat
Journal:  Mol Endocrinol       Date:  2003-10-02

9.  Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes.

Authors:  Lihong Cheng; Guoliang Ding; Qianhong Qin; Yan Xiao; David Woods; Yuqing E Chen; Qinglin Yang
Journal:  Biochem Biophys Res Commun       Date:  2004-01-09       Impact factor: 3.322

10.  Regulation of muscle fiber type and running endurance by PPARdelta.

Authors:  Yong-Xu Wang; Chun-Li Zhang; Ruth T Yu; Helen K Cho; Michael C Nelson; Corinne R Bayuga-Ocampo; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  PLoS Biol       Date:  2004-08-24       Impact factor: 8.029

View more
  49 in total

Review 1.  Maintaining ancient organelles: mitochondrial biogenesis and maturation.

Authors:  Rick B Vega; Julie L Horton; Daniel P Kelly
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

2.  Regulating PPARδ signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure.

Authors:  Ronald B Myers; Jun Yoshioka
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-13       Impact factor: 4.733

Review 3.  Cardiac nuclear receptors: architects of mitochondrial structure and function.

Authors:  Rick B Vega; Daniel P Kelly
Journal:  J Clin Invest       Date:  2017-02-13       Impact factor: 14.808

Review 4.  A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.

Authors:  Ashish Gupta; Brian Houston
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

5.  Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system.

Authors:  Teayoun Kim; Qinglin Yang
Journal:  World J Cardiol       Date:  2013-06-26

Review 6.  Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.

Authors:  Heinrich Taegtmeyer; Martin E Young; Gary D Lopaschuk; E Dale Abel; Henri Brunengraber; Victor Darley-Usmar; Christine Des Rosiers; Robert Gerszten; Jan F Glatz; Julian L Griffin; Robert J Gropler; Hermann-Georg Holzhuetter; Jorge R Kizer; E Douglas Lewandowski; Craig R Malloy; Stefan Neubauer; Linda R Peterson; Michael A Portman; Fabio A Recchia; Jennifer E Van Eyk; Thomas J Wang
Journal:  Circ Res       Date:  2016-03-24       Impact factor: 17.367

7.  Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.

Authors:  Huamei He; Hai Tao; Hui Xiong; Sheng Zhong Duan; Francis X McGowan; Richard M Mortensen; James A Balschi
Journal:  Toxicol Sci       Date:  2014-01-21       Impact factor: 4.849

8.  Stromal interaction molecule 1 is essential for normal cardiac homeostasis through modulation of ER and mitochondrial function.

Authors:  Helen E Collins; Lan He; Luyun Zou; Jing Qu; Lufang Zhou; Silvio H Litovsky; Qinglin Yang; Martin E Young; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-28       Impact factor: 4.733

9.  Activation of PPARδ prevents endothelial dysfunction induced by overexpression of amyloid-β precursor protein.

Authors:  Livius V d'Uscio; Pritam Das; Anantha V R Santhanam; Tongrong He; Steven G Younkin; Zvonimir S Katusic
Journal:  Cardiovasc Res       Date:  2012-08-10       Impact factor: 10.787

Review 10.  Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.

Authors:  Gregory Aubert; Rick B Vega; Daniel P Kelly
Journal:  Biochim Biophys Acta       Date:  2012-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.